Neonatal peripheral vascular access team
Abstract:
Intravenous vascular access (VA) is essential in neonatal intensive care units (NICUs). Short peripheral intravenous catheters (PIVCs) are the most frequently used short-term device.1 Many unmodifiable and potentially modifiable factors affect the incidence of complications, contributing to the success or failure of therapy.2 Numerous interventions such as evidence-based care bundles, innovations in device design and manufacturer are targeted at reducing the incidence and severity of complications.3 Internationally, specialist multiprofessional teams for central venous access are widely established4 but evidence about the impacts of teams for managing peripheral intravenous access is less evident.
Therefore, we aimed to examine the impacts of a dedicated neonatal peripheral vascular access team (NeoVAT) on key clinical and organisational quality measures of infusion therapy.
Reference:
van Rens M, Hugill K, Gaffari MAK, Francia AV, Ramkumar T, Garcia KLP, van Loon FHJ. Outcomes of establishing a neonatal peripheral vascular access team. Arch Dis Child Fetal Neonatal Ed. 2021 Oct 7:fetalneonatal-2021-322764. doi: 10.1136/archdischild-2021-322764. Epub ahead of print. PMID: 34620683.